NCT00500292 2018-01-25A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal CancerSanofiPhase 2 Completed109 enrolled 8 charts
NCT00508001 2016-10-10Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)SanofiPhase 2 Completed67 enrolled 12 charts